

ELITE Webcast
DRUG-DISEASE MODELLING:
The impact of early vs delayed initiation of combination therapy for BPH medical management
Watch expert discussion on clinical management now.
Adverse events should be reported to the Health Products Regulatory Authority (HPRA) using an Adverse Reaction Report Form obtained either from the HPRA or electronically via the website at www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Combodart is a registered trademark of the GlaxoSmithKline group of companies